Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407888
Status:
COMPLETED
Last Update Posted:
2017-08-31
First Post:
2006-12-04
Brief Title:
Doxorubicin Hydrochloride Cyclophosphamide and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
Sponsor:
University of Washington
Organization:
University of Washington
Organization Data
Organization:
University of Washington
Class:
OTHER
Study ID:
6141
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Washington
Lead Sponsor Class:
OTHER
Responsible Party:
Vijayakrishna Gadi
Responsible Party Title:
Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Washington
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |